Collaborative Resources for COVID-19 Research

A running list of resources, datasets, and infrastructure that support COVID-19 related research.

BU Resources

BU’s COVID-19 Research Projects Tracker (BU Kerberos log-in required) is a running list of research projects by BU faculty who are working to address the pandemic. You must first enable a BU Google Apps account to access this spreadsheet. You can also submit a project to the tracker using our COVID-19 research mobilization form.

Datasets & Publications

The COVID-19 Biorepository is an institutional resource available to Boston Medical Center (BMC) and BU researchers interested in biologic samples collected from BMC patients to support innovative science on the SARS-CoV-2 virus. Find a list of samples available on the Biorepository website.

COVID-19 Collaboration Platform is a website publicizing protocols that are open to collaboration so that researchers from different institutions can create multi-site protocols, add new sites to existing protocols and share de-identified data with other sites that are conducting similar studies.

COVID-19 Open Research Dataset (CORD-19) is a free resource of over 51,000 scholarly articles, including over 40,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community.

The iSearch COVID-19 portfolio is NIH’s comprehensive, curated source for publications related to COVID-19. This portfolio includes articles from PubMed and pre-prints from arXiv, medRxiv, bioRxiv, and ChemRxiv. The portfolio is updated daily with the latest available data.

Infrastructure

The Massachusetts Green High Performance Computing Center is providing its state of the art infrastructure for computationally intensive research at no cost for use in projects that could accelerate resolution of the COVID-19 crisis.

Ginkgo Bioworks has committed $25M of free access to foundry work towards projects that can use Ginkgo’s platform to accelerate development of point of care diagnostics, vaccines, or therapeutics for COVID-19.

Information For...